Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration - Genetic Engineering & Biotechnology News
Lilly, ImmuNext Launch Up-to-$605M+ Autoimmune Disease Collaboration Genetic Engineering & Biotechnology News
Eli Lilly will partner with ImmuNext to study and develop a preclinical novel potential target for autoimmune disease treatments, the companies said, through an ...
Comments
Post a Comment